Continuum Advisory’s iShares Biotechnology ETF IBB Stock Holding History

Continuum Advisory's IBB Position: Q2 2026 in Review

Continuum Advisory reduced its iShares Biotechnology ETF (IBB) stake by 19% in Q2 2026, selling an estimated $99.3K and leaving 2,468 shares worth $469K. The position accounts for 0.04% of the portfolio, ranked #304.

Continuum Advisory first reported a position in IBB in Q1 2023 and has held it in 12 quarters since. The position peaked at $1.93M in Q2 2023. 956 funds tracked by Wall St. Rank hold IBB as of Q2 2026.

• Continuum Advisory held 2,468 shares of iShares Biotechnology ETF worth $469K as of Q2 2026.
• Continuum Advisory sold 578 iShares Biotechnology ETF shares in Q2 2026, an estimated $99.3K.
• iShares Biotechnology ETF made up 0.04% of Continuum Advisory's portfolio in Q2 2026, its #304 holding.
• Continuum Advisory first reported a position in iShares Biotechnology ETF in Q1 2023 and has held it in 12 quarters since.
• Continuum Advisory's iShares Biotechnology ETF position peaked at $1.93M in Q2 2023.
• 956 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q2 2026.

Based on Continuum Advisory's 13F filing for Q2 2026, filed 6 Aug 2026.